NCT01952535View on ClinicalTrials.gov

A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of Oral HMS5552 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Type II Diabetes Mellitus
Interventions
DRUG

HMS5552

DRUG

Placebo

Trial Locations (1)

201203

Hua Medicine Limited, Shanghai

Sponsors
All Listed Sponsors
lead

Hua Medicine Limited

INDUSTRY

NCT01952535 - A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of Oral HMS5552 in Healthy Volunteers | Biotech Hunter | Biotech Hunter